keyword
https://read.qxmd.com/read/38613331/a-systematic-review-of-biobanks-in-latin-america-strengths-and-limitations-for-biomedical-research
#1
REVIEW
J Adrián Rivera-Alcántara, Natalia Esparza-Hurtado, Gabriela A Galán-Ramírez, Ivette Cruz-Bautista, Roopa Mehta, Carlos A Aguilar-Salinas, Alexandro J Martagon
Biobanks are valuable tools for developing and applying scientific research and international cooperation through the collection of biological materials and their associated data. Systematic research following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines was conducted in late 2022 in PubMed and Scopus, and generated 17 articles to be reviewed in depth and critically assessed using the Critical Appraisal Skills Programme Checklist due to the limited available data; 12 relevant health organizations and government websites outside of peer-reviewed journals were also included...
April 13, 2024: International Journal of Biological Markers
https://read.qxmd.com/read/38570208/insulin-resistance-potentiates-the-effect-of-remnant-cholesterol-on-cardiovascular-mortality-in-individuals-without-diabetes
#2
JOURNAL ARTICLE
Arsenio Vargas-Vázquez, Carlos A Fermín-Martínez, Neftali Eduardo Antonio-Villa, Luisa Fernández-Chirino, Daniel Ramírez-García, Gael Dávila-López, Juan Pablo Díaz-Sánchez, Carlos A Aguilar-Salinas, Jacqueline A Seiglie, Omar Yaxmehen Bello-Chavolla
BACKGROUND AND AIMS: Remnant cholesterol (RC) and insulin resistance (IR) have been independently associated with cardiovascular risk. Here, we evaluated the role of IR and RC on cardiovascular disease (CVD) mortality. METHODS: We conducted an analysis of 16,113 individuals ≥20 years without diabetes from the National Health and Nutrition Examination Survey (NHANES-III/IV). RC levels were calculated using total cholesterol, non-HDL-c, and LDL-c; IR was defined as HOMA2-IR≥2...
March 13, 2024: Atherosclerosis
https://read.qxmd.com/read/38537578/tuberculous-optochiasmatic-arachnoiditis
#3
JOURNAL ARTICLE
Luis A Robles, Pedro Aguilar-Salinas, Ian Côté
No abstract text is available yet for this article.
March 26, 2024: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38481899/outcomes-of-mechanical-thrombectomy-in-patients-with-neurological-disorders-a-national-inpatient-sample-database-analysis
#4
JOURNAL ARTICLE
Mohammad El-Ghanem, Hael Abdulrazeq, Leonardo Brasiliense, Hamza Abbad, Pedro Aguilar-Salinas, Fawaz Al-Mufti, Travis Dumont
INTRODUCTION: Mechanical thrombectomy (MT) has changed the standard of care for patients presenting with acute ischemic stroke (AIS). The window of treatment has significantly increased the number of patients who would benefit from intervention and operators may be confronted with patients harboring preexistent neurological disorders. Still, the epidemiology of patients with AIS and neurological disorders has not been established. METHODS: This is a retrospective study, which utilizes data from the National Inpatient Sample (NIS) between 2012 and 2016...
February 2024: Curēus
https://read.qxmd.com/read/38378924/personalized-versus-non-personalized-nutritional-recommendations-interventions-for-type%C3%A2-2-diabetes-mellitus-remission-a-narrative-review
#5
REVIEW
Ana T Arias-Marroquín, Fabiola M Del Razo-Olvera, Zaira M Castañeda-Bernal, Eustorgio Cruz-Juárez, María F Camacho-Ramírez, Daniel Elías-López, Miguel A Lara-Sánchez, Lucía Chalita-Ramos, Valeria Rebollar-Fernández, Carlos A Aguilar-Salinas
It is a well-evidenced fact that diet significantly impacts type 2 diabetes mellitus (T2DM) prevention and management. However, dietary responses vary among different populations, necessitating personalized recommendations. Substantial evidence supports the role of diet in T2DM remission, particularly low-energy or low-carbohydrate diets that facilitate weight loss, enhance glycemic control, and achieve remission. This review aims to comprehensively analyze and compare personalized nutritional interventions with non-personalized approaches in T2DM remission...
February 20, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38374256/genetic-drivers-of-heterogeneity-in-type-2-diabetes-pathophysiology
#6
JOURNAL ARTICLE
Ken Suzuki, Konstantinos Hatzikotoulas, Lorraine Southam, Henry J Taylor, Xianyong Yin, Kim M Lorenz, Ravi Mandla, Alicia Huerta-Chagoya, Giorgio E M Melloni, Stavroula Kanoni, Nigel W Rayner, Ozvan Bocher, Ana Luiza Arruda, Kyuto Sonehara, Shinichi Namba, Simon S K Lee, Michael H Preuss, Lauren E Petty, Philip Schroeder, Brett Vanderwerff, Mart Kals, Fiona Bragg, Kuang Lin, Xiuqing Guo, Weihua Zhang, Jie Yao, Young Jin Kim, Mariaelisa Graff, Fumihiko Takeuchi, Jana Nano, Amel Lamri, Masahiro Nakatochi, Sanghoon Moon, Robert A Scott, James P Cook, Jung-Jin Lee, Ian Pan, Daniel Taliun, Esteban J Parra, Jin-Fang Chai, Lawrence F Bielak, Yasuharu Tabara, Yang Hai, Gudmar Thorleifsson, Niels Grarup, Tamar Sofer, Matthias Wuttke, Chloé Sarnowski, Christian Gieger, Darryl Nousome, Stella Trompet, Soo-Heon Kwak, Jirong Long, Meng Sun, Lin Tong, Wei-Min Chen, Suraj S Nongmaithem, Raymond Noordam, Victor J Y Lim, Claudia H T Tam, Yoonjung Yoonie Joo, Chien-Hsiun Chen, Laura M Raffield, Bram Peter Prins, Aude Nicolas, Lisa R Yanek, Guanjie Chen, Jennifer A Brody, Edmond Kabagambe, Ping An, Anny H Xiang, Hyeok Sun Choi, Brian E Cade, Jingyi Tan, K Alaine Broadaway, Alice Williamson, Zoha Kamali, Jinrui Cui, Manonanthini Thangam, Linda S Adair, Adebowale Adeyemo, Carlos A Aguilar-Salinas, Tarunveer S Ahluwalia, Sonia S Anand, Alain Bertoni, Jette Bork-Jensen, Ivan Brandslund, Thomas A Buchanan, Charles F Burant, Adam S Butterworth, Mickaël Canouil, Juliana C N Chan, Li-Ching Chang, Miao-Li Chee, Ji Chen, Shyh-Huei Chen, Yuan-Tsong Chen, Zhengming Chen, Lee-Ming Chuang, Mary Cushman, John Danesh, Swapan K Das, H Janaka de Silva, George Dedoussis, Latchezar Dimitrov, Ayo P Doumatey, Shufa Du, Qing Duan, Kai-Uwe Eckardt, Leslie S Emery, Daniel S Evans, Michele K Evans, Krista Fischer, James S Floyd, Ian Ford, Oscar H Franco, Timothy M Frayling, Barry I Freedman, Pauline Genter, Hertzel C Gerstein, Vilmantas Giedraitis, Clicerio González-Villalpando, Maria Elena González-Villalpando, Penny Gordon-Larsen, Myron Gross, Lindsay A Guare, Sophie Hackinger, Liisa Hakaste, Sohee Han, Andrew T Hattersley, Christian Herder, Momoko Horikoshi, Annie-Green Howard, Willa Hsueh, Mengna Huang, Wei Huang, Yi-Jen Hung, Mi Yeong Hwang, Chii-Min Hwu, Sahoko Ichihara, Mohammad Arfan Ikram, Martin Ingelsson, Md Tariqul Islam, Masato Isono, Hye-Mi Jang, Farzana Jasmine, Guozhi Jiang, Jost B Jonas, Torben Jørgensen, Frederick K Kamanu, Fouad R Kandeel, Anuradhani Kasturiratne, Tomohiro Katsuya, Varinderpal Kaur, Takahisa Kawaguchi, Jacob M Keaton, Abel N Kho, Chiea-Chuen Khor, Muhammad G Kibriya, Duk-Hwan Kim, Florian Kronenberg, Johanna Kuusisto, Kristi Läll, Leslie A Lange, Kyung Min Lee, Myung-Shik Lee, Nanette R Lee, Aaron Leong, Liming Li, Yun Li, Ruifang Li-Gao, Symen Ligthart, Cecilia M Lindgren, Allan Linneberg, Ching-Ti Liu, Jianjun Liu, Adam E Locke, Tin Louie, Jian'an Luan, Andrea O Luk, Xi Luo, Jun Lv, Julie A Lynch, Valeriya Lyssenko, Shiro Maeda, Vasiliki Mamakou, Sohail Rafik Mansuri, Koichi Matsuda, Thomas Meitinger, Olle Melander, Andres Metspalu, Huan Mo, Andrew D Morris, Filipe A Moura, Jerry L Nadler, Michael A Nalls, Uma Nayak, Ioanna Ntalla, Yukinori Okada, Lorena Orozco, Sanjay R Patel, Snehal Patil, Pei Pei, Mark A Pereira, Annette Peters, Fraser J Pirie, Hannah G Polikowsky, Bianca Porneala, Gauri Prasad, Laura J Rasmussen-Torvik, Alexander P Reiner, Michael Roden, Rebecca Rohde, Katheryn Roll, Charumathi Sabanayagam, Kevin Sandow, Alagu Sankareswaran, Naveed Sattar, Sebastian Schönherr, Mohammad Shahriar, Botong Shen, Jinxiu Shi, Dong Mun Shin, Nobuhiro Shojima, Jennifer A Smith, Wing Yee So, Alena Stančáková, Valgerdur Steinthorsdottir, Adrienne M Stilp, Konstantin Strauch, Kent D Taylor, Barbara Thorand, Unnur Thorsteinsdottir, Brian Tomlinson, Tam C Tran, Fuu-Jen Tsai, Jaakko Tuomilehto, Teresa Tusie-Luna, Miriam S Udler, Adan Valladares-Salgado, Rob M van Dam, Jan B van Klinken, Rohit Varma, Niels Wacher-Rodarte, Eleanor Wheeler, Ananda R Wickremasinghe, Ko Willems van Dijk, Daniel R Witte, Chittaranjan S Yajnik, Ken Yamamoto, Kenichi Yamamoto, Kyungheon Yoon, Canqing Yu, Jian-Min Yuan, Salim Yusuf, Matthew Zawistowski, Liang Zhang, Wei Zheng, Leslie J Raffel, Michiya Igase, Eli Ipp, Susan Redline, Yoon Shin Cho, Lars Lind, Michael A Province, Myriam Fornage, Craig L Hanis, Erik Ingelsson, Alan B Zonderman, Bruce M Psaty, Ya-Xing Wang, Charles N Rotimi, Diane M Becker, Fumihiko Matsuda, Yongmei Liu, Mitsuhiro Yokota, Sharon L R Kardia, Patricia A Peyser, James S Pankow, James C Engert, Amélie Bonnefond, Philippe Froguel, James G Wilson, Wayne H H Sheu, Jer-Yuarn Wu, M Geoffrey Hayes, Ronald C W Ma, Tien-Yin Wong, Dennis O Mook-Kanamori, Tiinamaija Tuomi, Giriraj R Chandak, Francis S Collins, Dwaipayan Bharadwaj, Guillaume Paré, Michèle M Sale, Habibul Ahsan, Ayesha A Motala, Xiao-Ou Shu, Kyong-Soo Park, J Wouter Jukema, Miguel Cruz, Yii-Der Ida Chen, Stephen S Rich, Roberta McKean-Cowdin, Harald Grallert, Ching-Yu Cheng, Mohsen Ghanbari, E-Shyong Tai, Josee Dupuis, Norihiro Kato, Markku Laakso, Anna Köttgen, Woon-Puay Koh, Donald W Bowden, Colin N A Palmer, Jaspal S Kooner, Charles Kooperberg, Simin Liu, Kari E North, Danish Saleheen, Torben Hansen, Oluf Pedersen, Nicholas J Wareham, Juyoung Lee, Bong-Jo Kim, Iona Y Millwood, Robin G Walters, Kari Stefansson, Emma Ahlqvist, Mark O Goodarzi, Karen L Mohlke, Claudia Langenberg, Christopher A Haiman, Ruth J F Loos, Jose C Florez, Daniel J Rader, Marylyn D Ritchie, Sebastian Zöllner, Reedik Mägi, Nicholas A Marston, Christian T Ruff, David A van Heel, Sarah Finer, Joshua C Denny, Toshimasa Yamauchi, Takashi Kadowaki, John C Chambers, Maggie C Y Ng, Xueling Sim, Jennifer E Below, Philip S Tsao, Kyong-Mi Chang, Mark I McCarthy, James B Meigs, Anubha Mahajan, Cassandra N Spracklen, Josep M Mercader, Michael Boehnke, Jerome I Rotter, Marijana Vujkovic, Benjamin F Voight, Andrew P Morris, Eleftheria Zeggini
Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes1,2 and molecular mechanisms that are often specific to cell type3,4 . Here, to characterize the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases of T2D. We identify 1,289 independent association signals at genome-wide significance (P < 5 × 10-8 ) that map to 611 loci, of which 145 loci are, to our knowledge, previously unreported...
February 19, 2024: Nature
https://read.qxmd.com/read/38343412/managing-disease-modifying-antirheumatic-drugs-dmards-for-patients-undergoing-elective-spine-surgery-a-pilot-survey
#7
JOURNAL ARTICLE
James C Mamaril-Davis, Pedro Aguilar-Salinas, Salvador Fabián Gutiérrez Aguirre, Mauricio J Avila, Michel Villatoro-Villar, Katherine Riordan, Travis M Dumont
INTRODUCTION: Patients affected by autoimmune pathologies such as rheumatoid arthritis require surgery for various reasons. However, the systemic inflammatory nature of these disease processes often necessitates therapy with disease-modifying antirheumatic drugs (DMARDs). Alteration of these agents in the perioperative period for surgery requires a careful risk-benefit analysis to limit disease flares, infection rates, and secondary revisions. We therefore queried North and South American practices for perioperative management of DMARDs in patients undergoing elective spine surgery...
January 27, 2024: Spine surgery and related research
https://read.qxmd.com/read/38244782/de-escalating-treatment-indications-for-patients-who-achieve-metabolic-goals
#8
JOURNAL ARTICLE
Ana Cristina García-Ulloa, Salvador Jaime-Casas, Johanna Rosado-Lozoya, Nancy H Serrano-Pérez, Diana Hernández-Juárez, José Luis Cárdenas-Fragoso, Luis Eduardo Briones-García, Rodolfo Jiménez-Soto, Carlos García-Padilla, Juan García-Lara, Carlos A Aguilar-Salinas, Sergio Hernández-Jiménez
INTRODUCTION: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensification reduces overtreatment, polypharmacy, and risk of adverse effects. OBJECTIVE: To encompass current recommendations for deprescribing common drugs and create a consensus among health professionals. METHODS: We reviewed four databases for deprescribing approaches published between 2010-2022...
January 18, 2024: Diabetes Research and Clinical Practice
https://read.qxmd.com/read/38060942/-not-available
#9
JOURNAL ARTICLE
Ana Basto-Abreu, Nancy López-Olmedo, Rosalba Rojas-Martínez, Carlos A Aguilar-Salinas, Grea L Moreno-Banda, Martha Carnalla, Juan A Rivera, Martin Romero-Martinez, Simón Barquera, Tonatiuh Barrientos-Gutiérrez
OBJETIVO: Estimar la prevalencia de prediabetes y diabetes en la población adulta mexicana. Material y métodos. Se utilizó información de la submuestra de adultos de la Encuesta Nacional de Salud y Nutrición 2022 con una muestra de sangre de 10 ml. Se excluyeron 150 individuos con ayuno menor a 8 horas y cuatro personas con diabetes gestacional. La muestra final fue de 1 945 adultos que expande a 78.3 millones de adultos. RESULTADOS: La prevalencia de prediabetes fue de 22...
June 13, 2023: Salud Pública de México
https://read.qxmd.com/read/38060933/-not-available
#10
JOURNAL ARTICLE
Rosalba Rojas-Martínez, Consuelo Escamilla-Núñez, Lilia Castro-Porras, Ana Basto-Abreu, Tonatiuh Barrientos-Gutiérrez, Martín Romero-Martínez, Carlos Aguilar-Salinas
OBJETIVO: Describir las estimaciones de tamizaje, prevalencia, diagnóstico previo, tratamiento y control de hipertensión, hipercolesterolemia y diabetes, así como sus factores asociados en los adultos mexicanos. Material y métodos. Se utilizó información de los adultos de 20 años o más participantes de la Encuesta Nacional de Salud y Nutrición 2022 (Ensanut 2022). Se presentan estimaciones de prevalencias con sus intervalos de confianza al 95%, y modelos de regresión logística múltiple para cada padecimiento, con factores asociados al tamizaje, diagnóstico previo, tratamiento y control...
November 13, 2023: Salud Pública de México
https://read.qxmd.com/read/38060884/associated-factors-to-the-consumption-of-non-nutritive-sweeteners-in-the-mexican-adult-population
#11
JOURNAL ARTICLE
Alonso Romo-Romo, Lilia Castillo-Martínez, Carlos A Aguilar-Salinas, Griselda X Brito-Córdova, Alexandro J Martagón, Francisco J Gómez-Pérez, Paloma Almeda-Valdes
OBJECTIVE: To identify the associated factors to the consumption of non-nutritive sweeteners (NNS) in the Mexican adult population since its consumption has increased exponentially worldwide. MATERIALS AND METHODS: An online survey was applied to 5 038 Mexican adults to evaluate the frequency of NNS consumption and classify the population in tertiles. The sociodemographic, lifestyle and health status characteristics of the participants were compared by gradient of NNS consumption, and a multiple linear regression analysis was performed to determine the associated factors to the NNS consumption...
April 21, 2023: Salud Pública de México
https://read.qxmd.com/read/38056400/trends-in-the-mortality-of-diabetes-in-mexico-from-1998-to-2022-a%C3%A2-joinpoint-regression-and-age-period-cohort-effect-analysis
#12
JOURNAL ARTICLE
R Rojas-Martínez, C Escamilla-Nuñez, C A Aguilar-Salinas, L Castro-Porras, M Romero-Martínez, E Lazcano-Ponce
OBJECTIVE: The purpose was to analyze age-standardized trends in diabetes mortality rates (DMR) from 1998 to 2022, stratified by sex and Mexican state, and the effects attributable to age, period, and cohort by sex. STUDY DESIGN: Joinpoint regression and age-period-cohort effect analysis. METHODS: Based on the tenth revision of the International Classification of Diseases, E11, E12, E13, and E14 codes of the death certificate, a daily record of mortality was extracted from the death certificate attributable to diabetes as the main cause...
December 5, 2023: Public Health
https://read.qxmd.com/read/38008698/effect-of-a-monitored-exercise-protocol-in-cerebral-and-hepatic-hemodynamics-in-patients-with-cirrhosis-and-portal-hypertension
#13
JOURNAL ARTICLE
Ricardo U Macías-Rodríguez, Astrid Ruiz-Margáin, Berenice Román-Calleja, Carlos Cantú-Brito, Fernando Flores-Silva, Alejandro Gabutti-Thomas, Octavio Aguilar-Nájera, Mariana Cruz-Contreras, Lorena Weber-Sangri, Silvia Ríos-Torres, Aldo Torre Delgadillo, Carlos A Aguilar-Salinas, David Kershenobich-Stalnikowitz
BACKGROUND: Physical exercise (PE) has been proven to be beneficial in patients with cirrhosis; effects in cognitive function and cerebral hemodynamics, are yet to be explored. AIM: To evaluate the effects of a PE program (LFN-exercise protocol) in hepatic/cerebral hemodynamics. METHODS: Randomized open clinical trial in patients with cirrhosis; Control: Diet(n = 13),Intervention: Diet + exercise(n = 14) for 12 weeks...
November 25, 2023: Digestive and Liver Disease
https://read.qxmd.com/read/37992691/role-of-pre-surgical-gut-microbial-diversity-in-roux-en-y-gastric-bypass-weight-loss-response-a-cohort-study
#14
JOURNAL ARTICLE
Sofía Morán-Ramos, Ruth Soriano-Cortés, Valeria Soto-Fuentes, Amyris Tenorio-Quiroz, Emmanuel Gervasio-Ortiz, Dulce Rico-Amador, Miguel Herrera, Mauricio Sierra-Salazar, Carlos A Aguilar-Salinas, Barbara Antuna-Puente, Marcela Rodríguez-Flores
INTRODUCTION: Roux-en-Y gastric bypass substantially alters the gut microbial composition which could be associated with the metabolic improvements seen after surgery. Few studies have been conducted in Latin American populations, such as Mexico where obesity prevalence is above 30% in the adult population. Thus, the aim of this study was to characterize the changes in gut microbiota structure in a Mexican cohort before and after Roux-en-Y gastric bypass and to explore whether surgery-related changes in the microbial community were associated with weight loss...
November 22, 2023: Lifestyle Genomics
https://read.qxmd.com/read/37984194/performance-of-the-enhanced-sampson-nih-equation-for-vldl-c-and-ldl-c-in-a-population-with-familial-combined-hyperlipidemia
#15
JOURNAL ARTICLE
Rafael Zubirán, Arsenio Vargas-Vazquez, Fabiola Del Razo Olvera, Ivette Cruz-Bautista, Alexandro Martagón-Rosado, Maureen Sampson, Alan T Remaley, Carlos A Aguilar-Salinas
INTRODUCTION: Low-density cholesterol (LDL-C) has long been estimated by the Friedewald formula (F-LDL-C); however, this method underestimates LDL-C in patients with hypertriglyceridemia (HTG) or low LDL-C levels. The Martin (M-LDL-C) and Sampson (S-LDL-C) formulas partially resolve these limitations. Recently, Sampson et al. developed a new equation (eS-VLDL-C) that includes ApoB. This new equation could be particularly useful in FCHL, which is characterized by the predominance of triglyceride-rich VLDL and a discordance between LDL-C and ApoB...
November 6, 2023: Atherosclerosis
https://read.qxmd.com/read/37921916/stratification-in-heterozygous-familial-hypercholesterolemia-imaging-biomarkers-and-genetic-testing
#16
REVIEW
Pablo Corral, Carlos A Aguilar Salinas, María Gabriela Matta, Valeria Zago, Laura Schreier
PURPOSE OF REVIEW: Heterozygous familial hypercholesterolemia (HeFH) is the most common monogenic autosomal dominant disorder. However, the condition is often underdiagnosed and undertreated. The objective of this review is to provide an update on the risk stratification in patients with HeFH, incorporating new cardiovascular imaging techniques, various biomarkers, and genetic studies. RECENT FINDINGS: The diagnosis of HeFH places patients in a high cardiovascular risk category due to the increased incidence of premature atherosclerotic cardiovascular disease...
December 2023: Current Atherosclerosis Reports
https://read.qxmd.com/read/37821706/mexican-biobank-advances-population-and-medical-genomics-of-diverse-ancestries
#17
JOURNAL ARTICLE
Mashaal Sohail, María J Palma-Martínez, Amanda Y Chong, Consuelo D Quinto-Cortés, Carmina Barberena-Jonas, Santiago G Medina-Muñoz, Aaron Ragsdale, Guadalupe Delgado-Sánchez, Luis Pablo Cruz-Hervert, Leticia Ferreyra-Reyes, Elizabeth Ferreira-Guerrero, Norma Mongua-Rodríguez, Sergio Canizales-Quintero, Andrés Jimenez-Kaufmann, Hortensia Moreno-Macías, Carlos A Aguilar-Salinas, Kathryn Auckland, Adrián Cortés, Víctor Acuña-Alonzo, Christopher R Gignoux, Genevieve L Wojcik, Alexander G Ioannidis, Selene L Fernández-Valverde, Adrian V S Hill, María Teresa Tusié-Luna, Alexander J Mentzer, John Novembre, Lourdes García-García, Andrés Moreno-Estrada
Latin America continues to be severely underrepresented in genomics research, and fine-scale genetic histories and complex trait architectures remain hidden owing to insufficient data1 . To fill this gap, the Mexican Biobank project genotyped 6,057 individuals from 898 rural and urban localities across all 32 states in Mexico at a resolution of 1.8 million genome-wide markers with linked complex trait and disease information creating a valuable nationwide genotype-phenotype database. Here, using ancestry deconvolution and inference of identity-by-descent segments, we inferred ancestral population sizes across Mesoamerican regions over time, unravelling Indigenous, colonial and postcolonial demographic dynamics2-6 ...
October 11, 2023: Nature
https://read.qxmd.com/read/37804857/the-case-for-precision-medicine-in-the-prevention-diagnosis-and-treatment-of-cardiometabolic-diseases-in-low-income-and-middle-income-countries
#18
REVIEW
Shivani Misra, Carlos A Aguilar-Salinas, Tinashe Chikowore, Flemming Konradsen, Ronald C W Ma, Lilian Mbau, Viswanathan Mohan, Robert W Morton, Moffat J Nyirenda, Neo Tapela, Paul W Franks
Cardiometabolic diseases are the leading preventable causes of death in most geographies. The causes, clinical presentations, and pathogenesis of cardiometabolic diseases vary greatly worldwide, as do the resources and strategies needed to prevent and treat them. Therefore, there is no single solution and health care should be optimised, if not to the individual (ie, personalised health care), then at least to population subgroups (ie, precision medicine). This optimisation should involve tailoring health care to individual disease characteristics according to ethnicity, biology, behaviour, environment, and subjective person-level characteristics...
November 2023: Lancet Diabetes & Endocrinology
https://read.qxmd.com/read/37790638/the-trend-in-the-prevalence-of-diabetes-mellitus-in-the-mexican-indigenous-population-from-2000-to-2018
#19
JOURNAL ARTICLE
Lilia V Castro-Porras, Rosalba Rojas-Martínez, Martín Romero-Martínez, Carlos A Aguilar-Salinas, Consuelo Escamilla-Nuñez
INTRODUCTION: Diabetes is a worldwide public health problem. In Mexico, diabetes was the third leading cause of death in the total population in 2020. The indigenous people in Mexico are approximately 6%. This study aims to estimate the trends in diabetes prevalence from 2000 to 2018 in the group of Mexican indigenous language speakers and to analyze the main sociodemographic (e.g., age, educational and socioeconomic level, and the urbanicity of the area of residence) and clinical (e...
June 2023: AJPM Focus
https://read.qxmd.com/read/37630477/safety-and-tolerability-of-six-months-of-isoniazid-plus-pyridoxine-or-three-months-of-rifampicin-for-tuberculosis-among-subjects-with-diabetes-mellitus-a-randomized-trial
#20
JOURNAL ARTICLE
Karla M Tamez-Torres, Norma Mongua-Rodríguez, Leticia Ferreyra-Reyes, Pedro Torres-Gonzalez, Guadalupe Delgado-Sánchez, Maribel Martínez-Hernández, Miriam Bobadilla-Del-Valle, Velma Y Jasso-Sosa, Priscila Del S López-Castillo, Elizabeth Ferreira-Guerrero, Luis Pablo Cruz-Hervert, Jose Sifuentes-Osornio, Carlos A Aguilar-Salinas, Lourdes García-García, Alfredo Ponce-de-Leon
Tuberculosis (TB) associated with diabetes mellitus (DM) is a growing problem, particularly in low- and medium-resource countries. We conducted an open-label, parallel-group, randomized, and controlled trial in a tertiary care center in Mexico City to assess TB preventive treatment (TPT) with isoniazid (INH) or rifampicin (RIF) in people with type 2 DM. Participants were assigned six months of INH 300 mg/day plus pyridoxine 75 mg or three months of RIF 600 mg/day. The primary outcomes were adverse events resulting in permanent treatment cessation and considered possibly or probably related to study drugs...
July 28, 2023: Microorganisms
keyword
keyword
70405
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.